Latest filing published 06 Oct 2026 for RELAY THERAPEUTICS INC, €1.6M.
Insider track record
No signal scores available.
Thomas Catinazzo: trading record in brief
Thomas Catinazzo discloses dealings in Relay Therapeutics, Inc. to SEC (Form 4). Between 22 June 2026 and 6 October 2026, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 6 October 2026 came the latest disclosure, a transaction for €1.6M in Relay Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas Catinazzo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 93,153 shares@ US$19.39CommonSEC144:0001950047-26-010071
- 204,880 shares@ US$15.880.074% mcap100.0% of flowCommonSEC144:0001950047-26-006398
2 of 2 declarations
